Earnings · China A-shares
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A (600332) earnings
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A published its Q3 report on 2026-10-28: net profit -24.73% year on year, -22.50% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +2.10% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -24.73%
- Excl. one-offs YoY
- -22.50%
- Net profit QoQ
- +26.74%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.87% | — |
| 3 days | +2.10% | — |
| 7 days | +2.87% | — |
| 14 days | +0.77% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.20%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥2.49B | -24.73% | -22.50% | +0.76% | 1.53 | 6.43% | +2.10% | — | — |
| 2026 interim report | 2026-08-22 | ¥2.10B | -16.70% | -12.10% | +0.61% | 1.29 | 5.40% | -2.10% | -2.52% | +4.39% |
| 2026 Q1 report | 2026-04-28 | ¥1.78B | -2.06% | +1.72% | +3.58% | 1.10 | 4.61% | +1.62% | -4.04% | -3.42% |
| 2025 annual report | 2026-03-21 | ¥2.98B | +5.21% | +0.29% | +3.55% | 1.83 | 8.09% | -7.36% | -9.63% | -16.81% |
| 2025 Q3 report | 2025-10-29 | ¥3.31B | +4.78% | +0.48% | +4.31% | 2.04 | 8.88% | +3.09% | +0.04% | +3.51% |
| 2025 interim report | 2025-08-16 | ¥2.52B | -1.31% | -5.78% | +1.93% | 1.55 | 6.77% | +2.01% | -5.33% | -13.64% |
| 2025 Q1 report | 2025-04-30 | ¥1.82B | -6.99% | -8.67% | -2.06% | 1.12 | 4.95% | +3.54% | +3.38% | +0.21% |
| 2024 annual report | 2025-03-14 | ¥2.84B | -30.09% | -35.18% | -0.69% | 1.74 | 7.99% | -1.32% | -4.45% | +0.23% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.